Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
Chong Huang, Huiping Shuai, Jingxin Qiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
EBioMedicine (2023) Vol. 90, pp. 104545-104545
Open Access | Times Cited: 44
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
EBioMedicine (2023) Vol. 95, pp. 104753-104753
Open Access | Times Cited: 38
Evolution of the SARS-CoV-2 Omicron spike
Ruth Parsons, Priyamvada Acharya
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113444-113444
Open Access | Times Cited: 35
Altered host protease determinants for SARS-CoV-2 Omicron
Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 32
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Luis Daniel González-Vázquez, Miguel Arenas
Genes (2023) Vol. 14, Iss. 2, pp. 407-407
Open Access | Times Cited: 29
Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
Panke Qu, John P. Evans, Chaitanya Kurhade, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 26
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
Shuai Xia, Lijue Wang, Fanke Jiao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 20
Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides
Yue Hu, Yuanmei Zhu, Yanying Yu, et al.
Antiviral Research (2023) Vol. 212, pp. 105571-105571
Open Access | Times Cited: 18
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
Jimena Pérez‐Vargas, Gabriel Lemieux, Connor A.H. Thompson, et al.
Antiviral Research (2024) Vol. 225, pp. 105869-105869
Open Access | Times Cited: 6
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
Ruipeng Lei, Enya Qing, Abby Odle, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Genomic surveillance of SARS‐CoV‐2 strains circulating in Iran during six waves of the pandemic
Kaveh Sadeghi, Sevrin Zadheidar, Arghavan Zebardast, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 4
Open Access | Times Cited: 13
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS‐CoV‐2 Omicron Variants
Shuo Liu, Pan Liu, Qiong Lu, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Open Access
RAB5 is a host dependency factor for the generation of SARS-CoV-2 replication organelles
Yuexuan Chen, Susanne Klute, Konstantin M. J. Sparrer, et al.
mBio (2025)
Open Access
CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex
Ildar Gabaev, Alexandra Rowland, Emilija Jovanovic, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Overview of SARS-CoV-2 variants in the federation of Bosnia and Herzegovina throughout four waves of the pandemic
Ivana Čeko, Naida Mulahuseinović, Selma Durgut, et al.
Technology and Health Care (2025)
Closed Access
COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses
Yanxia Chen, Wenchen Song, Can Li, et al.
EBioMedicine (2023) Vol. 89, pp. 104485-104485
Open Access | Times Cited: 10
Omicron‐induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection
Denisa Bojková, Marco Bechtel, Tamara Rothenburger, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 10
Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants
Yoshikazu Honda‐Okubo, Anna Antipov, Greiciely O. André, et al.
Immunology (2023) Vol. 170, Iss. 2, pp. 193-201
Closed Access | Times Cited: 10
SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency
Romano Strobelt, Karin Broennimann, Julia Adler, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1129-1129
Open Access | Times Cited: 10
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract
Bingjie Hu, Jasper Fuk‐Woo Chan, Yuanchen Liu, et al.
EBioMedicine (2023) Vol. 99, pp. 104916-104916
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top